Treatment of polyradiculopathy herpes zoster
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
I have enough information to provide a comprehensive answer. Let me compile the findings.
Herpes Zoster Polyradiculopathy — Treatment
Overview
Herpes zoster (VZV reactivation) produces radiculopathy via inflammation and neuronal loss in the dorsal root ganglia (DRG) at the affected segmental levels. In the setting of segmental zoster paresis, there is lymphocytic inflammation and vasculitis involving adjacent motor roots and spinal cord gray matter with resulting motor fiber degeneration. A complication of cutaneous herpes zoster, segmental motor weakness occurs in up to 30% of patients with zoster reactivation. — Bradley and Daroff's Neurology in Clinical Practice
Antiviral Therapy (Cornerstone of Treatment)
The major goals of treatment are to relieve local discomfort, prevent dissemination, and reduce the severity of postherpetic neuralgia (PHN).
| Setting | Agent | Regimen | Duration |
|---|---|---|---|
| Immunocompetent, >50 years, uncomplicated | Acyclovir, valacyclovir, or famciclovir (oral) | Standard oral dosing | 7–10 days |
| Disseminated zoster, CNS/spinal involvement, severe immunosuppression | Acyclovir IV | 10 mg/kg q8h | 10–14 days |
| Viral myelitis/radiculopathy (including herpes zoster) | IV acyclovir or oral valacyclovir | IV: 10 mg/kg q8h; Oral: 2 g TID | 10–14 days |
| Herpes zoster ophthalmicus | Valacyclovir (preferred) + ophthalmology consult | Standard oral dosing | — |
"Herpes zoster, HSV, and EBV myelitis are treated with intravenous acyclovir (10 mg/kg q8h) or oral valacyclovir (2 g tid) for 10–14 days." — Harrison's Principles of Internal Medicine, 22e
Timing is critical:
- Start within 72 hours of rash onset for maximum benefit
- Consider initiating >72 hours if new vesicles are still forming
- Immunocompromised patients: treat regardless of time since rash onset — Tintinalli's Emergency Medicine
Antivirals Reduce but Do Not Eliminate PHN
Oral antivirals (acyclovir, valacyclovir, famciclovir) can shorten the duration of blistering lesions and reduce acute pain but do not reduce the severity of postherpetic neuralgia. However, IV acyclovir followed by oral valacyclovir was found to reduce pain of PHN in >50% of treated patients. — Bradley and Daroff's Neurology in Clinical Practice
Pain Management
- Acute pain: Herpes zoster can be extremely painful and may require opioid analgesia
- Corticosteroids (adjunctive, combined with antivirals): provide modest decrease in acute pain but do not decrease PHN risk; may be considered in older patients with severe pain without contraindications
- PHN treatment (when pain persists >30 days after rash): combinations of:
- Tricyclic antidepressants (amitriptyline)
- SSRIs (sertraline, nefazodone)
- Anticonvulsants (gabapentin, carbamazepine)
- Oral opioids (oxycodone)
- Topical agents: capsaicin cream or lidocaine patches
- Singly or in combination, effective in ~50% of patients — Bradley and Daroff's Neurology in Clinical Practice
Special Situations
CMV polyradiculopathy (important differential in HIV/AIDS with CD4 <50):
- Treated with ganciclovir 5 mg/kg IV BID + foscarnet 60 mg/kg IV TID, or cidofovir
- Distinct from VZV — different treatment entirely — Harrison's Principles of Internal Medicine, 22e
Prognosis of zoster motor radiculopathy:
- Nearly complete return of function in two-thirds of patients over 1–2 years
- 55% full recovery; ~30% significant improvement
- ~20% left with severe permanent residua — Bradley and Daroff's Neurology in Clinical Practice
Summary
Herpes zoster polyradiculopathy is treated primarily with high-dose IV acyclovir (10 mg/kg q8h × 10–14 days) for cases with neurological involvement, or oral valacyclovir (2 g TID × 10–14 days) as an alternative for less severe presentations. Pain management is multimodal. Immunocompromised patients warrant more aggressive, early treatment regardless of the timing of rash onset.
Herpes zoster severe neuritis treatment
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, high-quality content from multiple authoritative sources. Here is the synthesized answer:
Herpes Zoster Severe Neuritis — Treatment
The most debilitating complication of herpes zoster is pain associated with acute neuritis and its sequela, postherpetic neuralgia (PHN). In patients >50 years old, at least 50% report pain in the involved dermatome for months after resolution of cutaneous disease. — Harrison's Principles of Internal Medicine, 22e
1. Antiviral Therapy (Start Immediately)
Antivirals accelerate healing of lesions and resolution of zoster-associated pain. Preferred agents (superior pharmacokinetics to acyclovir):
| Agent | Dose | Duration |
|---|---|---|
| Valacyclovir (preferred) | 1 g PO TID | 5–7 days |
| Famciclovir (preferred) | 500 mg PO TID | 7 days |
| Acyclovir | 800 mg PO 5× daily | 7–10 days |
| IV Acyclovir (severe/immunocompromised) | 10 mg/kg IV q8h | 7 days |
- Start within 72 hours of rash onset; consider starting later if new vesicles are still forming
- Immunocompromised patients (transplant recipients, lymphoma, lymphoproliferative malignancies): treat with IV acyclovir at the outset, regardless of timing
- Antivirals reduce the duration of acute neuritis pain but have limited effect on established PHN severity — Harrison's Principles of Internal Medicine, 22e
2. Glucocorticoids for Severe Acute Neuritis
Glucocorticoid therapy administered early in the course of localized herpes zoster significantly accelerates quality-of-life improvements — return to usual activity and termination of analgesic use.
Prednisone regimen (orally):
- Days 1–7: 60 mg/day
- Days 8–14: 30 mg/day
- Days 15–21: 15 mg/day
"This regimen is appropriate only for relatively healthy elderly persons with moderate or severe pain at presentation." — Harrison's Principles of Internal Medicine, 22e
Contraindications to steroids: osteoporosis, diabetes mellitus, glycosuria, hypertension.
Critical rule: never use glucocorticoids without concomitant antiviral therapy.
3. Analgesia for Acute Neuritis
A stepwise approach, escalating as needed:
- Non-narcotic analgesics (NSAIDs, acetaminophen) — first step
- Opioid analgesics — for severe pain; zoster neuritis frequently requires opioid-level analgesia
- Gabapentin / Pregabalin — neuropathic pain modulation; evidence-based for both acute neuritis and PHN
- Amitriptyline (tricyclic antidepressant) — particularly effective; limited by anticholinergic side effects in elderly
- Flupenazine — reportedly beneficial adjunct for pain — Harrison's Principles of Internal Medicine, 22e
4. Sympathetic/Regional Nerve Blocks (Acute Phase)
Sympathetic blocks performed during the acute episode often produce excellent analgesia and may reduce the risk of PHN:
- When initiated within 2 months of rash onset, PHN resolves in up to 80% of patients in some studies
- Once PHN is well established, sympathetic blocks become generally ineffective
- Epidural steroid injections have NOT been proven to prevent PHN — Morgan and Mikhail's Clinical Anesthesiology, 7e
5. Treatment of Established PHN (Chronic Severe Neuritis)
When pain persists >30 days after rash, evidence-based therapies include:
| Drug Class | Agent |
|---|---|
| Anticonvulsants | Gabapentin, Pregabalin |
| Tricyclic antidepressants | Amitriptyline, nortriptyline |
| Opioid analgesics | Oxycodone, tramadol |
| Topical agents | 5% Lidocaine patch (most convenient) |
| High-concentration topical | Capsaicin 8% patch (Qutenza — must be administered in monitored setting; pretreat with EMLA cream 1h before to reduce procedural pain) |
| Topical capsaicin cream | Low-concentration preparation |
On average, these agents provide adequate pain relief (reduction to <3/10 or ≥50% reduction) in 30–60% of patients. Choice should be guided by adverse event profile, patient comorbidities, and drug interactions. — Fitzpatrick's Dermatology; Morgan and Mikhail's Clinical Anesthesiology, 7e
6. Special Situations
Zoster ophthalmicus with neuritis:
- Immediate ophthalmology referral
- Systemic antivirals (valacyclovir preferred) + analgesics + atropine
- Corticosteroid use decided by ophthalmologist
- Complications to monitor: uveitis, keratitis, optic neuritis, acute retinal necrosis — Andrews' Diseases of the Skin; Kanski's Clinical Ophthalmology
Zoster sine herpete (pain without rash):
- Simulates herniated disc; diagnosed by VZV PCR from CSF or blood
- Treat identically once confirmed
Prevention (Shingrix Vaccine)
- Shingrix (recombinant subunit HZ/su, 2 doses 1 month apart) for all immunocompetent individuals ≥50 years: 97.2% efficacy against zoster, and reduces severity of PHN
- Strongly recommended to prevent acute neuritis altogether — Harrison's Principles of Internal Medicine, 22e; Morgan and Mikhail's Clinical Anesthesiology, 7e
This is a shared conversation. Sign in to Orris to start your own chat.